Why do I have yellow bumps around my eyes?

Yellow bumps around your eyes are likely xanthelasma, cholesterol deposits that form when lipids accumulate under the skin. While often harmless cosmetically, they can signal underlying cholesterol problems or cardiovascular risk, making lipid testing essential.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

What Are These Yellow Bumps?

Those yellowish, slightly raised bumps around your eyes have a medical name: xanthelasma palpebrarum. These soft, flat or slightly elevated patches typically appear on the upper or lower eyelids, most commonly near the inner corner of the eye. They're actually cholesterol deposits that have accumulated beneath the skin's surface, creating visible yellowish plaques that can range from a few millimeters to several centimeters in size.

Xanthelasma affects approximately 4% of the population and becomes more common with age, typically appearing after age 40. Women are slightly more likely to develop these bumps than men. While they're usually painless and don't affect vision, many people find them cosmetically concerning. More importantly, their presence can sometimes indicate underlying metabolic issues that deserve medical attention.

The Cholesterol Connection

Xanthelasma forms when lipids, particularly cholesterol esters, accumulate in specialized immune cells called macrophages within the skin. These foam cells cluster together in the dermis, creating the characteristic yellow appearance. The process is similar to what happens in arterial walls during atherosclerosis development, which explains why xanthelasma can sometimes signal cardiovascular risk.

Cholesterol Levels and Xanthelasma Risk

Lipid abnormalities are present in approximately 50% of xanthelasma cases.
Lipid MarkerNormal RangeAssociated with XanthelasmaClinical Significance
Total CholesterolTotal Cholesterol<200 mg/dL>240 mg/dLHigh levels increase xanthelasma risk
LDL CholesterolLDL Cholesterol<100 mg/dL>160 mg/dLPrimary driver of cholesterol deposits
HDL CholesterolHDL Cholesterol>40 mg/dL (men), >50 mg/dL (women)<40 mg/dLLow levels reduce cholesterol clearance
TriglyceridesTriglycerides<150 mg/dL>200 mg/dLOften elevated in xanthelasma patients
ApoBApoB<90 mg/dL>110 mg/dLBetter predictor than LDL alone

Lipid abnormalities are present in approximately 50% of xanthelasma cases.

Interestingly, about half of people with xanthelasma have normal cholesterol levels, while the other half have dyslipidemia (abnormal lipid levels). When cholesterol abnormalities are present, they typically involve elevated total cholesterol, high LDL cholesterol, low HDL cholesterol, or elevated triglycerides. Understanding your complete lipid profile through comprehensive testing can help determine whether your xanthelasma is linked to systemic cholesterol issues.

The relationship between xanthelasma and cholesterol metabolism is complex. Even in people with normal blood lipid levels, local factors in the eyelid skin may promote cholesterol accumulation. These factors include altered local lipid metabolism, increased vascular permeability, or inflammatory processes that attract lipid-laden macrophages to the area.

Risk Factors and Associated Conditions

Primary Risk Factors

Several factors increase your likelihood of developing xanthelasma. Age is a significant factor, with most cases occurring in people over 40. Genetic predisposition plays a crucial role, particularly in familial hypercholesterolemia, where xanthelasma can appear even in younger individuals. Gender also matters, as women, especially post-menopausal women, have a slightly higher incidence rate.

  • Family history of xanthelasma or high cholesterol
  • Obesity or being overweight
  • Diabetes mellitus (Type 1 or Type 2)
  • Hypothyroidism
  • Primary biliary cirrhosis
  • Chronic kidney disease
  • Certain medications (corticosteroids, estrogen, tamoxifen)

Metabolic Syndrome Connection

Xanthelasma frequently appears alongside metabolic syndrome components. People with these bumps often have insulin resistance, central obesity, hypertension, and dyslipidemia. This clustering of risk factors significantly increases cardiovascular disease risk, making xanthelasma a potential visible marker of metabolic dysfunction that warrants comprehensive health evaluation.

Health Implications Beyond Appearance

While xanthelasma itself is benign and doesn't threaten vision or eye health, research shows it can be an important predictor of cardiovascular disease. Studies have found that people with xanthelasma have a 48% higher risk of heart attack, 39% higher risk of ischemic heart disease, and 14% higher risk of severe atherosclerosis compared to those without these lesions.

The presence of xanthelasma may indicate accelerated aging of the cardiovascular system. Even in individuals with normal cholesterol levels, xanthelasma is associated with increased carotid intima-media thickness, a marker of early atherosclerosis. This suggests that the same processes causing visible cholesterol deposits in the eyelids may be occurring in blood vessels throughout the body.

Additionally, xanthelasma has been linked to increased all-cause mortality, particularly when combined with arcus corneae (a gray or white arc visible around the cornea). This combination suggests more severe lipid metabolism dysfunction and warrants aggressive cardiovascular risk factor modification. If you notice these yellow bumps developing, it's essential to get comprehensive metabolic and cardiovascular testing to understand your overall health status.

Upload your blood test results to track your progress

Seamlessly upload 3rd party biomarker & blood tests to track your whole health in 1 dashboard. Understand what each blood test means and how it fits into the bigger picture of your body and health.

Get diet and lifestyle recommendations based on your blood results, health profile and health goals. You'll also receive a custom supplement recommendation for the precise nutrients your body craves.

Upload Past Blood Test Results

Click or drag file to upload

Once you upload your report, we'll extract the results for your review. Works with top labs including Quest Diagnostics, LabCorp, BioReference, EverlyWell, LetsGetChecked and hundreds of other labs.

Diagnosis and Medical Evaluation

Clinical Diagnosis

Diagnosing xanthelasma is typically straightforward based on visual examination. Dermatologists or ophthalmologists can usually identify these lesions by their characteristic appearance: yellowish, soft, flat or slightly raised plaques on the eyelids. In rare cases where the diagnosis is uncertain, a skin biopsy may be performed to confirm the presence of lipid-laden foam cells.

Essential Laboratory Tests

Once xanthelasma is identified, comprehensive lipid testing becomes crucial. Your healthcare provider should order a complete lipid panel including total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides, and ideally apolipoprotein B (ApoB) and lipoprotein(a). Additional tests might include fasting glucose, HbA1c, thyroid function tests (TSH, Free T3, Free T4), and liver function tests to identify underlying conditions contributing to lipid abnormalities.

For a complete understanding of your metabolic health and cardiovascular risk, consider uploading your existing blood test results to SiPhox Health's free analysis service. This AI-powered tool can help you understand your results in context and identify patterns that might be contributing to xanthelasma development.

Treatment Options and Management

Medical Management

Treating underlying lipid abnormalities is the first step in managing xanthelasma. If blood tests reveal dyslipidemia, your doctor may prescribe statins, which can help reduce cholesterol levels and potentially slow the progression of xanthelasma. Other lipid-lowering medications like ezetimibe, PCSK9 inhibitors, or fibrates might be considered based on your specific lipid profile. However, it's important to note that medical treatment rarely causes existing xanthelasma to disappear completely.

Cosmetic Removal Procedures

For those seeking removal of xanthelasma for cosmetic reasons, several options exist:

  • Surgical excision: Direct removal with a scalpel, effective but may leave scars
  • Laser therapy: CO2 or erbium YAG lasers can vaporize the lesions with minimal scarring
  • Chemical cauterization: Application of trichloroacetic acid (TCA) to destroy the deposits
  • Cryotherapy: Freezing the lesions with liquid nitrogen
  • Radiofrequency ablation: Using heat to destroy the cholesterol deposits

Recurrence rates after removal range from 40-60%, especially if underlying metabolic issues aren't addressed. The best outcomes occur when cosmetic treatment is combined with aggressive management of cholesterol levels and cardiovascular risk factors.

Prevention and Lifestyle Modifications

Preventing xanthelasma or its recurrence requires a comprehensive approach to metabolic health. Dietary modifications play a crucial role: reducing saturated and trans fats, increasing fiber intake, and following a Mediterranean-style diet can help optimize lipid levels. Regular physical activity, aiming for at least 150 minutes of moderate-intensity exercise weekly, improves cholesterol metabolism and insulin sensitivity.

Weight management is particularly important, as even modest weight loss can significantly improve lipid profiles. If you have diabetes or prediabetes, maintaining good glycemic control helps prevent lipid abnormalities. Limiting alcohol intake and avoiding smoking are also essential, as both can worsen dyslipidemia and accelerate atherosclerosis.

Regular monitoring of your lipid levels and other metabolic markers helps track progress and adjust treatment strategies. Consider testing every 3-6 months if you're actively working to improve your cholesterol levels or have been diagnosed with xanthelasma. This frequency allows you to see how lifestyle changes and treatments are affecting your metabolic health.

When to Seek Medical Attention

You should consult a healthcare provider if you notice any yellowish bumps developing around your eyes, even if they're small and painless. Early evaluation can identify underlying metabolic issues before they lead to more serious cardiovascular problems. Seek immediate attention if xanthelasma appears suddenly or grows rapidly, as this might indicate severely elevated cholesterol levels requiring urgent treatment.

Additionally, see your doctor if you have xanthelasma along with symptoms like chest pain, shortness of breath, or leg pain with walking, as these could indicate advanced atherosclerosis. Family members of people with xanthelasma should also consider lipid screening, especially if there's a family history of early heart disease or high cholesterol.

Living with Xanthelasma: Long-term Outlook

The prognosis for people with xanthelasma varies depending on underlying health factors. Those with normal cholesterol levels and no other cardiovascular risk factors generally have an excellent outlook, though the lesions may persist or slowly enlarge over time. For individuals with dyslipidemia or other metabolic conditions, the focus should be on comprehensive cardiovascular risk reduction rather than just cosmetic concerns.

Success in managing xanthelasma requires patience and commitment to long-term health optimization. While the bumps themselves are harmless, they serve as a visible reminder to maintain vigilance about cardiovascular health. Regular monitoring, adherence to treatment plans, and lifestyle modifications can prevent progression and reduce the risk of serious cardiovascular events.

Remember that xanthelasma is often just the tip of the iceberg when it comes to metabolic health. By addressing it comprehensively through proper testing, treatment, and lifestyle changes, you're not just improving your appearance but potentially adding years to your life and life to your years. The yellow bumps around your eyes might actually be doing you a favor by alerting you to take action before more serious problems develop.

References

  1. Christoffersen M, Frikke-Schmidt R, Schnohr P, et al. Xanthelasmata, arcus corneae, and ischaemic vascular disease and death in general population: prospective cohort study. BMJ. 2011;343:d5497.[PubMed][DOI]
  2. Zak A, Zeman M, Slaby A, Vecka M. Xanthomas: clinical and pathophysiological relations. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2014;158(2):181-188.[PubMed][DOI]
  3. Nair PA, Singhal R. Xanthelasma palpebrarum - a brief review. Clin Cosmet Investig Dermatol. 2017;11:1-5.[PubMed][DOI]
  4. Dey A, Aggarwal R, Dwivedi S. Cardiovascular Profile of Xanthelasma Palpebrarum. Biomed Res Int. 2013;2013:932863.[PubMed][DOI]
  5. Pandhi D, Gupta P, Singal A, Tondon A, Sharma S. Xanthelasma palpebrarum: a marker of premature atherosclerosis. Postgrad Med J. 2012;88(1038):198-204.[PubMed][DOI]
  6. Jain A, Goyal P, Nigam PK, Gurbaksh H, Sharma RC. Xanthelasma Palpebrarum-clinical and biochemical profile in a tertiary care hospital of Delhi. Indian J Clin Biochem. 2007;22(2):151-153.[PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my cholesterol at home?

You can test your cholesterol at home with SiPhox Health's Heart & Metabolic Program, which includes comprehensive lipid testing including HDL, LDL, triglycerides, and ApoB. This CLIA-certified program provides lab-quality results from the comfort of your home.

Are yellow bumps around eyes always xanthelasma?

While xanthelasma is the most common cause of yellow bumps around the eyes, other conditions like syringomas, milia, or sebaceous hyperplasia can appear similar. A dermatologist can provide accurate diagnosis through visual examination or biopsy if needed.

Can xanthelasma go away on its own?

Xanthelasma rarely disappears without treatment. Even with cholesterol-lowering medications, existing lesions typically persist. Cosmetic removal procedures are usually needed to eliminate them, though recurrence is common if underlying metabolic issues aren't addressed.

Does having xanthelasma mean I have high cholesterol?

Not necessarily. About 50% of people with xanthelasma have normal cholesterol levels. However, its presence warrants comprehensive lipid testing since it can indicate cardiovascular risk even with normal cholesterol.

What's the best treatment for removing xanthelasma?

The most effective treatments include surgical excision, laser therapy, and chemical cauterization with trichloroacetic acid. Choice depends on lesion size, location, and individual factors. Combining removal with cholesterol management reduces recurrence risk.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details